“Synthesis and docking studies of new 5-bromoindole-2-carboxylic acid oxadiazole derivatives as EGFR inhibitors”, Tikrit J. Pharm. Sci., vol. 17, no. 1, pp. 58–77, Jun. 2023, doi: 10.25130/tjphs.2023.17.1.6.58.77 .